10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

35 library items in 10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

10: Musculoskeletal and joint diseases (remove) , 10.3 Drugs for the relief of soft-tissue inflammat (remove) , 10.3.2 Rubefacients, topical NSAIDs, capsaicin, an (remove)

Sort by: Display summary:

Results 1 - 10 of 35

Result page:
Previous
|
1
2
3
4
|
Next

1.

AWMSG issues Final Appraisal Recommendation on capsaicin 8% patch (Qutenza®) for peripheral neuropathic pain in non-diabetic patients

Source: All Wales Medicines Strategy Group (AWMSG),
Date published: 09/03/2012

Category:

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | All Wales Medicines Strategy Group (AWMSG) | Neurological injury | Pain control

NeLM Area:

Evidence > Drug Specific Reviews

AWMSG Final Appraisal Recommendation – 0412: Capsaicin patch (Qutenza®) February 2012
2.

Direct Healthcare Professional Communication on risk minimisation measures for ketoprofen-containing topical formulations

Source: MHRA,
Date published: 05/03/2012

Category:

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Dermatology | Medicines and Healthcare products Regulatory Agency (MHRA) | Pain control

NeLM Area:

News

Link to communication

Link to EMA review conclusion (NeLM report)
3.

US FDA panel votes against recommending Qutenza® capsaicin patch for neuropathic pain in HIV

Source: BioSpace ,
Date published: 13/02/2012

Category:

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Food &Drug Administration (FDA) | Horizon scanning | Pain control

NeLM Area:

News

Link
4.

NETAG issues recommendation on capsaicin cutaneous patch (Qutenza®) for neuropathic pain

Source: NETAG ,
Date published: 14/10/2011

Category:

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Drug reviews | Neurology | Pain control

NeLM Area:

Evidence > Drug Specific Reviews

Recommendation

Appraisal report
5.

SMC accepts capsaicin cutaneous patch (Qutenza®) for restricted use

Source: Scottish Medicines Consortium (SMC),
Date published: 07/02/2011

Category:

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Drug reviews | Neurology | Pain control | Scottish Medicines Consortium

NeLM Area:

Evidence > Drug Specific Reviews

Link (drug advice)
6.

MHRA consults on reclassification of Ibusol lotion from POM to P

Source: MHRA,
Date published: 03/02/2011

Category:

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Law/ medical ethics/ litigation | Medicines and Healthcare products Regulatory Agency (MHRA) | OTC medicines | Prescribing and supply of medicines

NeLM Area:

News

Link
7.

Pharmacological interventions for pain in patients with temporomandibular disorders

Source: Cochrane Library,
Date published: 15/12/2010

Category:

4.1.1 Hypnotics | 4.7.3 Neuropathic pain | 10.1 Drugs used in rheumatic diseases and gout | 10.1.1 Non-steroidal anti-inflammatory drugs | 10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Drug reviews | Ear, Nose and Throat (ENT) disorders | Pain control | Rheumatology

NeLM Area:

Evidence > Disease Focused Reviews

Abstract
8.

MHRA consultation on reclassifying Radian B Ibuprofen 5% w/w Gel 100G from Pharmacy (P) to General Sales List (GSL)

Source: MHRA,
Date published: 05/11/2010

Category:

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Law/ medical ethics/ litigation | Medicines and Healthcare products Regulatory Agency (MHRA) | OTC medicines | Rheumatology

NeLM Area:

News

Link
9.

Topical treatments for osteoarthritis of the knee

Source: DARE,
Date published: 08/10/2010

Category:

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Osteoarthritis

NeLM Area:

Evidence > Disease Focused Reviews

DARE abstract
10.

MHRA reminder of risk of photosensitivity reactions with topical ketoprofen

Source: Drug Safety Update,
Date published: 09/08/2010

Category:

10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices | Adverse Drug Reactions | Dermatology | Medicines and Healthcare products Regulatory Agency (MHRA)

NeLM Area:

Evidence > Medication Safety

Drug Safety Update

EMEA review and recommendations (NeLM news item)

Results 1 - 10 of 35

Result page:
Previous
|
1
2
3
4
|
Next